Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
about
The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responsesAutoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyRecent advances in primary Sjogren's syndromeExtrahepatic manifestations of chronic hepatitis C virus infectionReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementAntigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 DiabetesInducing and Administering Tregs to Treat Human DiseaseApplication of IL-2 therapy to target T regulatory cell functionImmune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceHomeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic TregsLow-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunityFrom IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokinesThe place of immunotherapy in the management of HCV-induced vasculitis: an updateImmunotherapy in autoimmune type 1 diabetesRegulatory T-cell therapy in transplantation: moving to the clinicIL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetesProspects for therapeutic tolerance in humans.Interleukin-22 in kidney injury and regeneration.Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current PerspectivesConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseHepatitis C Therapy in Renal Patients: Who, How, When?Inhibition of G-protein βγ signaling enhances T cell receptor-stimulated interleukin 2 transcription in CD4+ T helper cellsLPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activityA Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic SyndromeRegulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialProtocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive studyThe expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal injury.Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel functionPeg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia.FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability.IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized MiceLow-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseasesRationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial.Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII.Human IL-6RhiTIGIT- CD4+CD127lowCD25+ T cells display potent in vitro suppressive capacity and a distinct Th17 profile.Hepatitis C virus associated glomerulopathies.Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.
P2860
Q24616434-F40A81A4-CB0F-4B70-AA83-70E58C252C05Q26742101-CD97BC29-2BB8-49CF-978D-B6AE1E03613CQ26747049-5BEAA3AC-D9D3-44E1-A674-3A6F8DEDF2FEQ26767084-4C613347-3919-4909-B1FD-F39FC768B6CDQ26769878-C8DB98AC-9DDA-4A93-BA84-841AD9A0BDCCQ26770386-D51B6A58-AAF4-42DA-98F6-2B9809ADA40FQ26772723-668097E2-0B47-4BC6-8F1B-CB6C4A13F104Q26827327-E59FEF26-269D-4A9C-B8FD-86919A3C8EBBQ26850621-A45F77B0-0E0A-485F-9276-B189DAC9F3E2Q26853599-035CDD6F-3344-4655-A55F-864437E8C2EFQ27008200-9E401488-7869-4EFD-90D6-22694F10CEBBQ27008912-053ECA90-2C4F-4CAF-A1BA-A0A4244A4390Q27015124-B2C5B736-6E25-4355-9470-EA9675E5ABBCQ27025619-D7C386C3-52AC-4B54-B0A5-AE1C45487359Q27025869-5EA07EEF-BB28-44F9-BD44-02B130461E36Q27303126-8B761AA0-DA83-45AA-A0DB-ADB0146FF80BQ27318199-EE4B0376-7B85-442F-AF8F-13B95DB7BE24Q27687335-EF3328AE-8E6C-4CB2-BB1A-73F4426C5D08Q28069832-CB50E989-6CEA-4AC3-9E27-EAB7EB8C769AQ28071490-1B0AFEC9-8D2E-41DF-A62C-BD6A6A72078EQ28076264-71164B78-33AA-4B4A-98E6-5D1C3C15726AQ28077130-33B457B3-5734-4282-880A-600FBE52FBCFQ28543127-F94AE203-8EA1-443F-8064-0E736ADABC02Q28544395-C9A9AE64-21D2-40EB-917D-135C5152F6C5Q28548569-0094F6FD-F740-435D-A809-27C20D936560Q28554636-CE38B68E-4D13-461B-A7D2-13C5DAB29849Q28604189-AB332613-9888-428E-97BD-4839022DB983Q30251847-0B723E9A-2895-423A-BE3B-19AB1A162368Q30252348-AFBE9BEE-C6BD-490C-B2C2-6671DAB63890Q30819489-0FBCE563-93B0-4348-A263-25A94A280BA4Q33407192-B2DA3E50-B41B-42FB-A7B7-78CFDD9672FFQ33436930-F9E4FAE1-D3F1-4489-8D7F-5CBC5B9CC237Q33580878-99F63EEE-989D-4B31-8863-C2E7B7519DB9Q33586165-F5E98E22-21F2-46A7-9043-0FB358147457Q33650813-55A07EC4-97A4-4505-8539-B6D78D3CE7C8Q33744839-96496344-772A-41EF-834B-3A69A4E31E8DQ33748093-CA481908-DF91-4367-AFF0-25620771BD9FQ33800947-7E5BEA3C-0847-4108-AD16-3DD41B66DB17Q33801278-D74195CF-2C89-4C0B-AE90-E9638769E023Q33811204-915A71DA-D231-4E61-A6E4-52F7EAEC2B49
P2860
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@en
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@nl
type
label
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@en
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@nl
prefLabel
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@en
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@nl
P2093
P50
P356
P1476
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
@en
P2093
Damien Sene
David Saadoun
Florence Joly
Vincent Thibault
P304
P356
10.1056/NEJMOA1105143
P407
P577
2011-12-01T00:00:00Z